See how others have used ER alpha Antibody (HC-20). Click on the entry to view the PubMed entry .
PMID: # 27009360
Totta, P. et al. 2016. Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation. Scientific reports. 6: 23727.
PMID: # 26987957
Mitrović, N. et al. 2016. 17β-Estradiol upregulates ecto-5'-nucleotidase (CD73) in hippocampal synaptosomes of female rats through action mediated by estrogen receptor-α and -β. Neuroscience. 324: 286-96.
PMID: # 26763249
Vareslija, D. et al. 2016. Adaptation to AI therapy in breast cancer can induce dynamic alterations in ER activity resulting in estrogen independent metastatic tumours. Clinical cancer research : an official journal of the American Association for Cancer Research.
PMID: # 26137275
He, DE. et al. 2015. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus. Molecular and clinical oncology. 3: 607-612.
PMID: # 26348925
Pesiri, V. et al. 2015. Estrogen Receptor α L429 and A430 Regulate 17β-estradiol-induced cell proliferation via CREB1. Cellular signalling.
PMID: # 25860340
Totta, P. et al. 2015. Clathrin heavy chain interacts with estrogen receptor α and modulates 17β-estradiol signaling. Molecular endocrinology (Baltimore, Md.). me20141385.
PMID: # 26480297
Totta, P. et al. 2015. Modulation of 17β-estradiol signaling on cellular proliferation by caveolin-2. Journal of cellular physiology.
PMID: # 26079946
Ma, S. et al. 2015. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 6: 13320-33.
PMID: # 25582774
Patki, M. et al. 2015. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells. Biochemical and biophysical research communications. 457: 404-11.
PMID: # 26080448
Gao, WW. et al. 2015. Arginine methylation of HSP70 regulates retinoid acid-mediated RARβ2 gene activation. Proceedings of the National Academy of Sciences of the United States of America. 112: E3327-36.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.